Article Information
- Received December 23, 2002
- Revision received February 12, 2003
- Accepted February 18, 2003
- Published in print May 1, 2003.
Author Information
- 1 Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 469, Centre National de la Recherche Scientifique/INSERM de Pharmacologie et d'Endocrinologie, 34094 Montpellier Cedex 5, France, and
- 2 Division of Molecular Neurobiology, National Institute for Medical Research, London NW7 1AA, United Kingdom
Author contributions
Disclosures
- Received December 23, 2002.
- Revision received February 12, 2003.
- Accepted February 18, 2003.
-
This work was supported by grants from the Institut National de la Santé et de la Recherche Médicale, Région Languedoc-Roussillon, Association pour la Recherche sur le Cancer, and Fondation pour la Recherche Médicale. We thank Drs. U. Gerber and P. Mollard for critical reading of this manuscript and M. Passama, A. Carrette, and D. Haddou for their excellent technical assistance. We thank Dr. C. Gotti for kindly providing the F3 compound.
-
Correspondence should be addressed to Nathalie C. Guérineau, Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 469, Centre National de la Recherche Scientifique/INSERM de Pharmacologie et d'Endocrinologie, 141 rue de la Cardonille, 34094 Montpellier Cedex 5, France. E-mail: nathalie.guerineau{at}ccipe.cnrs.fr.
Statistics from Altmetric.com
Article usage
In this issue
